Advisory Services Network, LLC Global Blood Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$25.48 - $37.34 $917 - $1,344	-36 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$32.46 - $43.42 $1,168 - $1,563	36 New	36 $1,000
Q1 2021 May 24, 2021	SELL	$38.94 - $50.85 $1,401 - $1,830	-36 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$37.65 - $63.77 $865 - $1,466	-23 Reduced 38.98%	36 $2,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $299,465 - $422,805	-5,676 Reduced 98.97%	59 $3,000
Q2 2020 Aug 10, 2020	SELL	$48.73 - $81.82 $2,533 - $4,254	-52 Reduced 0.9%	5,735 $362,000
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $83 - $174	2 Added 0.03%	5,787 $296,000
Q4 2019 Feb 04, 2020	SELL	$45.7 - $81.86 $14,943 - $26,768	-327 Reduced 5.35%	5,785 $460,000
Q2 2019 Aug 01, 2019	BUY	$52.6 - $63.29 $5,523 - $6,645	105 Added 1.75%	6,112 $0
Q1 2019 May 20, 2019	BUY	$39.99 - $53.48 $240,219 - $321,254	6,007 New	6,007 $318,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.